Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Gage

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Blood|February 6, 2008
CYP4F2 genetic variant alters required warfarin doseMichael D Caldwell, Tarif Awad, Julie A Johnson, et al.
American Heart Journal|September 11, 2013
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trialStephen E Kimmel, Benjamin French, Jeffrey L Anderson, et al.
Blood|March 6, 2010
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groupsNita A Limdi, Mia Wadelius, Larisa Cavallari, et al.
Stroke|February 27, 2023
Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual WorkshopAlan S Go, Sana M Al-Khatib, Patrice Desvigne-Nickens, et al.
JAMA|October 4, 2017
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
JAMA|September 4, 2019
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
Thrombosis and Haemostasis|December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyBenjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Circulation|June 29, 2011
American Heart Association atrial fibrillation research summit: a conference report from the American Heart AssociationN A Mark Estes, Ralph L Sacco, Sana M Al-Khatib, et al.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Blood|February 6, 2008
CYP4F2 genetic variant alters required warfarin doseMichael D Caldwell, Tarif Awad, Julie A Johnson, et al.
American Heart Journal|September 11, 2013
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trialStephen E Kimmel, Benjamin French, Jeffrey L Anderson, et al.
Blood|March 6, 2010
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groupsNita A Limdi, Mia Wadelius, Larisa Cavallari, et al.
Stroke|February 27, 2023
Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual WorkshopAlan S Go, Sana M Al-Khatib, Patrice Desvigne-Nickens, et al.
JAMA|October 4, 2017
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
JAMA|September 4, 2019
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.
Thrombosis and Haemostasis|December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyBenjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Circulation|June 29, 2011
American Heart Association atrial fibrillation research summit: a conference report from the American Heart AssociationN A Mark Estes, Ralph L Sacco, Sana M Al-Khatib, et al.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
Pageof 14